• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌肿瘤免疫微环境的研究进展:文献综述

Advances in tumor immune microenvironment of head and neck squamous cell carcinoma: A review of literature.

机构信息

Department of Otorhinolaryngology Head and Neck Surgery, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China.

Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital, Hainan Medical University, Haikou, China.

出版信息

Medicine (Baltimore). 2024 Mar 1;103(9):e37387. doi: 10.1097/MD.0000000000037387.

DOI:10.1097/MD.0000000000037387
PMID:38428879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10906580/
Abstract

Squamous cell carcinoma is seen as principal malignancy of head and neck. Tumor immune microenvironment plays a vital role in the occurrence, development and treatment of head and neck squamous cell carcinoma (HNSCC). The effect of immunotherapy, in particular, is closely related to tumor immune microenvironment. This review searched for high-quality literature included within PubMed, Web of Science, and Scopus using the keywords "head and neck cancers," "tumor microenvironment" and "immunotherapy," with the view to summarizing the characteristics of HNSCC immune microenvironment and how various subsets of immune cells promote tumorigenesis. At the same time, based on the favorable prospects of immunotherapy having been shown currently, the study is committed to pinpointing the latest progress of HNSCC immunotherapy, which is of great significance in not only further guiding the diagnosis and treatment of HNSCC, but also conducting its prognostic judgement.

摘要

鳞状细胞癌被视为头颈部的主要恶性肿瘤。肿瘤免疫微环境对头颈部鳞状细胞癌(HNSCC)的发生、发展和治疗起着至关重要的作用。免疫疗法的效果尤其与肿瘤免疫微环境密切相关。本综述通过关键词“头颈癌”、“肿瘤微环境”和“免疫疗法”,在 PubMed、Web of Science 和 Scopus 中搜索了高质量的文献,旨在总结 HNSCC 免疫微环境的特征以及各种免疫细胞亚群如何促进肿瘤发生。同时,鉴于目前免疫疗法的前景看好,本研究致力于确定 HNSCC 免疫疗法的最新进展,这不仅对头颈部鳞状细胞癌的诊断和治疗具有重要意义,而且对头颈部鳞状细胞癌的预后判断也具有重要意义。

相似文献

1
Advances in tumor immune microenvironment of head and neck squamous cell carcinoma: A review of literature.头颈部鳞状细胞癌肿瘤免疫微环境的研究进展:文献综述
Medicine (Baltimore). 2024 Mar 1;103(9):e37387. doi: 10.1097/MD.0000000000037387.
2
Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.人乳头瘤病毒阳性头颈部鳞状细胞癌的免疫微环境。
Sci Prog. 2024 Jan-Mar;107(1):368504241237888. doi: 10.1177/00368504241237888.
3
Comprehensive investigation into the influence of glycosylation on head and neck squamous cell carcinoma and development of a prognostic model for risk assessment and anticipating immunotherapy.全面研究糖基化对头颈部鳞状细胞癌的影响,并开发一种用于风险评估和预测免疫治疗的预后模型。
Front Immunol. 2024 Mar 18;15:1364082. doi: 10.3389/fimmu.2024.1364082. eCollection 2024.
4
Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.全面描绘肿瘤微环境,评估头颈部鳞状细胞癌患者的免疫治疗效果。
Aging (Albany NY). 2020 Nov 18;12(22):22509-22526. doi: 10.18632/aging.103460.
5
Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.鉴定和验证与自噬、细胞凋亡和焦亡相关基因的头颈部鳞状细胞癌预后标志物:提示 HPV 阴性患者的治疗选择。
Front Immunol. 2023 Jan 10;13:1100417. doi: 10.3389/fimmu.2022.1100417. eCollection 2022.
6
Immune deserts in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment.头颈部鳞状细胞癌中的免疫荒漠:肿瘤免疫微环境调节的挑战与机遇综述。
Oral Oncol. 2021 Sep;120:105420. doi: 10.1016/j.oraloncology.2021.105420. Epub 2021 Jul 1.
7
: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma.一个与头颈部鳞状细胞癌免疫浸润和免疫治疗反应相关的预后生物标志物。
Bioengineered. 2022 May;13(5):13784-13800. doi: 10.1080/21655979.2022.2084254.
8
Tumor immune microenvironment in head and neck cancers.头颈部癌症中的肿瘤免疫微环境。
Mol Carcinog. 2020 Jul;59(7):766-774. doi: 10.1002/mc.23162. Epub 2020 Feb 3.
9
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.一项经过元验证的免疫浸润相关基因模型可预测头颈部鳞状细胞癌的预后和免疫治疗敏感性。
BMC Cancer. 2023 Jan 13;23(1):45. doi: 10.1186/s12885-023-10532-y.
10
An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.一个与血管生成相关的基因特征,可预测头颈部鳞状细胞癌患者的预后和免疫治疗疗效。
J Cancer Res Clin Oncol. 2024 Feb 12;150(2):91. doi: 10.1007/s00432-024-05606-8.

引用本文的文献

1
A novel mast cell marker gene-related prognostic signature to predict prognosis and reveal the immune landscape in head and neck squamous cell carcinoma.一种用于预测头颈部鳞状细胞癌预后并揭示其免疫格局的新型肥大细胞标志物基因相关预后特征。
Front Immunol. 2025 Jul 9;16:1538641. doi: 10.3389/fimmu.2025.1538641. eCollection 2025.
2
Advances and challenges in immunotherapy in head and neck cancer.头颈部癌免疫治疗的进展与挑战
Front Immunol. 2025 Jun 6;16:1596583. doi: 10.3389/fimmu.2025.1596583. eCollection 2025.
3
Multi-omics and machine learning-driven CD8 T cell heterogeneity score for head and neck squamous cell carcinoma.

本文引用的文献

1
Immunometabolism in the tumor microenvironment and its related research progress.肿瘤微环境中的免疫代谢及其相关研究进展
Front Oncol. 2022 Oct 31;12:1024789. doi: 10.3389/fonc.2022.1024789. eCollection 2022.
2
The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy.T细胞在头颈部鳞状细胞癌中的作用:从免疫到免疫治疗。
Front Oncol. 2022 Oct 20;12:1021609. doi: 10.3389/fonc.2022.1021609. eCollection 2022.
3
Advances in nuclear medicine-based molecular imaging in head and neck squamous cell carcinoma.
多组学和机器学习驱动的头颈部鳞状细胞癌CD8 T细胞异质性评分
Mol Ther Nucleic Acids. 2024 Dec 5;36(1):102413. doi: 10.1016/j.omtn.2024.102413. eCollection 2025 Mar 11.
4
Effect of group management on disease cognition and fear of disease progression, nutritional status, and quality of life in patients with head and neck tumors.小组管理对头颈部肿瘤患者疾病认知、疾病进展恐惧、营养状况及生活质量的影响。
Am J Transl Res. 2024 Dec 15;16(12):7937-7947. doi: 10.62347/CBKG3767. eCollection 2024.
头颈部鳞状细胞癌核医学分子影像的进展。
J Transl Med. 2022 Aug 12;20(1):358. doi: 10.1186/s12967-022-03559-5.
4
FGF-2 signaling in nasopharyngeal carcinoma modulates pericyte-macrophage crosstalk and metastasis.成纤维细胞生长因子 2 信号在鼻咽癌中的作用调节周细胞-巨噬细胞串扰和转移。
JCI Insight. 2022 May 23;7(10):e157874. doi: 10.1172/jci.insight.157874.
5
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.EB 病毒诱导的异位 CD137 表达帮助鼻咽癌逃避免疫监视,并使嵌合抗原受体能够靶向该肿瘤。
Cancer Immunol Immunother. 2022 Nov;71(11):2583-2596. doi: 10.1007/s00262-022-03183-8. Epub 2022 Mar 17.
6
EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1.EBV 微小 RNA BART11 和 BART17-3p 通过增强子介导的 PD-L1 转录促进免疫逃逸。
Nat Commun. 2022 Feb 14;13(1):866. doi: 10.1038/s41467-022-28479-2.
7
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.纳武利尤单抗联合伊匹单抗新辅助免疫治疗可诱导头颈部鳞状细胞癌患者发生主要病理缓解。
Nat Commun. 2021 Dec 22;12(1):7348. doi: 10.1038/s41467-021-26472-9.
8
Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO.巨噬细胞重编程与癌症治疗学:iNOS 衍生的 NO 的作用。
Cells. 2021 Nov 16;10(11):3194. doi: 10.3390/cells10113194.
9
Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy.肿瘤微环境中 MDSCs 的代谢重编程及其在癌症免疫治疗中的靶向作用。
Acta Pharmacol Sin. 2022 Jun;43(6):1337-1348. doi: 10.1038/s41401-021-00776-4. Epub 2021 Sep 24.
10
TIM-3 and CEACAM1 are Prognostic Factors in Head and Neck Squamous Cell Carcinoma.TIM-3和癌胚抗原相关细胞黏附分子1是头颈部鳞状细胞癌的预后因素。
Front Mol Biosci. 2021 Jul 23;8:619765. doi: 10.3389/fmolb.2021.619765. eCollection 2021.